References
- Fabre R, Berry A, Morassin B, et al. Comparative assessment of conventional PCR with multiplex real-time PCR using SYBR Green I detection for the molecular diagnosis of imported malaria. Parasitology. 2004;128:15–21. doi: 10.1017/S0031182003004219
- Witkowski B, Duru V, Khim N, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis. 2017;17:174–183. doi: 10.1016/S1473-3099(16)30415-7
- Baker J, McCarthy J, Gatton M, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis. 2005;192:870–877. doi: 10.1086/432010
- WHO | World malaria report 2018 [Internet]. WHO [cited 2020 Mar 26]. Available from: http://www.who.int/malaria/publications/world-malaria-report-2018/report/en/
- WHO | Malaria diagnosis - new perspectives [Internet]. WHO [cited 2020 Mar 26]. Available from: https://www.who.int/tdr/publications/tdr-research-publications/malaria-diagnosis/en/
- Baker J, Ho M-F, Pelecanos A, et al. Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J. 2010;9:129. doi: 10.1186/1475-2875-9-129
- Cheng Q, Gatton ML, Barnwell J, et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J. 2014;13:283. doi: 10.1186/1475-2875-13-283
- Beshir KB, Sepúlveda N, Bharmal J, et al. Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya. Sci Rep. [Internet] 2017 [cited 2020 Jul 30];7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677122/.
- Grignard L, Nolder D, Sepúlveda N, et al. A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections. EBioMedicine [Internet] 2020 [cited 2020 Jul 23];55. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218259/.
- Girma S, Cheaveau J, Mohon AN, et al. Prevalence and epidemiological characteristics of asymptomatic malaria based on ultrasensitive diagnostics: a cross-sectional study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;69:1003–1010. doi: 10.1093/cid/ciy1005
- Berhane A, Anderson K, Mihreteab S, et al. Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea. Emerg Infect Dis. 2018;24:462–470. doi: 10.3201/eid2403.171723
- Watson OJ, Verity R, Ghani AC, et al. Impact of seasonal variations in Plasmodium falciparum malaria transmission on the surveillance of pfhrp2 gene deletions. eLife. 2019;8:e40339. doi: 10.7554/eLife.40339
- WHO | Country profiles [Internet]. WHO [cited 2020 Mar 26]. Available from: http://www.who.int/malaria/publications/country-profiles/profile_dji_en.pdf?ua=1
- Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–55. doi: 10.1038/nature12876
- WHO. Response plan to pfhrp2 gene deletions. 2019 [cited 2020 Mar 26]. Available from: https://apps.who.int/iris/handle/10665/325528
- Kamaliddin C, Le Bouar M, Berry A, et al. Assessment of diagnostic methods for imported malaria in mainland France. Med Mal Infect. 2020;50:141–160. doi: 10.1016/j.medmal.2019.07.007
- Lalloo DG, Shingadia D, Bell DJ, et al. UK malaria treatment guidelines 2016. J Infect. 2016;72:635–649. doi: 10.1016/j.jinf.2016.02.001